Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes
AssigneeThe United States of America as represented by the Department of Health and Human Services
InventorGeorge N. Pavlakis
Life of this patent
Estimating the term…
Abstract
Nucleic acid constructs containing HIV-1 gag/pol and SIV gag or SIV genes which have been mutated to remove or reduce inhibitory/instability sequences are disclosed. Viral particles and host cells containing these constructs and/or viral particles are also disclosed. The exemplified constructs and viral particles of the invention may be useful in gene therapy for numerous disorders, including HIV infection, or as a vaccine for HIV-1 immunotherapy and immunoprophylaxis.
Claims35
A nucleic acid construct comprising a HIV-1 gag/pol gene having the coding sequence of the gag/pol gene set forth in FIG. 1.
A nucleic acid construct comprising a HIV-1 pol gene having the coding sequence of the pol gene set forth in FIG. 2.
A nucleic acid construct comprising a SIV-1 gag gene having the coding sequence of the gag gene set forth in FIG. 3.
A nucleic acid construct comprising an HIV or SIV 5′ LTR, a packaging signal, a gag/pol gene comprising the sequence set forth in FIG. 1, a 5′ splice site, a 3′ splice site, an env gene, a tat gene, a functional RNA transport element and a 3′ HIV or SIV LTR, said nucleic acid construct being able to produce functional Gag, Pol and Env virion components.
A lentiviral expression system comprising the following:
- (a) a packaging vector comprising a HIV-1 gag/pol gene having the nucleotide sequence set forth in FIG. 1:
- (b) a transfer vector;
- and
- (c) an envelope encoding vector.
A process for making a lentiviral particle comprising expressing HIV Gag and HIV Pol in a host cell from a vector comprising the nucleotide sequences encoding HIV Gag and HIV Pol set forth in FIG. 1 in the presence of a gene encoding an envelope protein.
A lentiviral expression system which is capable of functioning in the absence of Rev, Tat, and any viral RNA transport element comprising the following:
- (a) a packaging vector comprising a HIV-1 gag/pol gene which has been mutated to eliminate inhibitory/instability regions;
- (b) a transfer vector;
- and
- (c) an envelope encoding vector.
A process for making a lentiviral particle in the absence of Rev, Tat, or any viral RNA transport element comprising expressing HIV Gag and HIV Pol in a host cell from a HIV-1 gag/pol gene which has been mutated to eliminate inhibitory/instability regions and expressing an Envelope protein from a envelope encoding gene whose expression is independent Rev, Tat, or any viral RNA transport element.
A nucleic acid construct comprising a SIV-1 env gene having the coding sequence of the env gene set forth in FIG. 16.
Dependencies are inferred from the claim text.